JZJ(SH:605266) Xin Lang Zheng Quan·2025-12-22 06:06Core Viewpoint - The stock price of Jianzhijia has experienced a decline of 10.20% year-to-date, with a recent drop of 2.03% on December 22, 2025, indicating potential challenges in the company's market performance [2][1]. Company Overview - Jianzhijia Pharmaceutical Chain Group Co., Ltd. is located in Kunming, Yunnan Province, and was established on September 27, 2004. It was listed on December 1, 2020. The company specializes in the retail of health products, including pharmaceuticals, health foods, personal care items, and daily consumables [2]. - The revenue composition of Jianzhijia includes 72.60% from prescription and non-prescription drugs (with non-prescription drugs at 39.64% and prescription drugs at 32.96%), 7.44% from medical devices, and smaller percentages from other categories such as health foods and personal care products [2]. Financial Performance - For the period from January to September 2025, Jianzhijia reported a revenue of 6.549 billion yuan, a year-on-year decrease of 2.77%, and a net profit attributable to shareholders of 101 million yuan, down 0.22% year-on-year [2]. - The company has distributed a total of 715 million yuan in dividends since its A-share listing, with 473 million yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, Jianzhijia had 15,100 shareholders, a slight decrease of 0.04% from the previous period, with an average of 10,240 circulating shares per shareholder, which increased by 0.04% [2]. - Among the top ten circulating shareholders, the Rongtong Health Industry Flexible Allocation Mixed A/B Fund holds 7.1 million shares, unchanged from the previous period, while the Guangfa Innovation Upgrade Mixed Fund has exited the top ten list [3].